Method B
(3,3-difluoroazetidin-1-yl)-[6-[4-[4-(1H-pyrazol-5-yl)anilino]pyrimidin-2-yl]-1H-benzimidazol-2-yl]methanone
Molecular Identity
Method B
(3,3-difluoroazetidin-1-yl)-[6-[4-[4-(1H-pyrazol-5-yl)anilino]pyrimidin-2-yl]-1H-benzimidazol-2-yl]methanone
PubChem CID: 177269633
2D Structure
Properties
C24H18F2N8O
Molecular Formula
472.40
Molecular Weight
g/mol
472.1572
Exact Mass
Da
3.5
XLogP
Drug-like (Lipinski: < 5)
115
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
8
H-Bond Acceptors
758
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(3)
Method BBDBM772161US20250289807, Example 21
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Method B
Loading drug network...